E-LIB Suche - Ergebnisse für: Mulas, O.

1

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Ver..:

Palandri, F. ; Auteri, G. ; Abruzzese, E....
Annals of Hematology. 103 (2024) 6 - p. 1931-1940 , 2024

Link: https://doi.org/10.1007/..

2

Safety and efficacy of caplacizumab retreatment in a real-l..:

Caocci, G. ; Mulas, O. ; Mantovani, D...
Thrombosis Research. 228 (2023) - p. 189-190 , 2023

Link: https://doi.org/10.1016/..

3

Thyroid autoimmunity and hypothyroidism are associated with..:

Rodia, R. ; Pani, F. ; Caocci, G....
Journal of Endocrinological Investigation. 45 (2021) 2 - p. 291-300 , 2021

Link: https://doi.org/10.1007/..

4

Determinants of frontline tyrosine kinase inhibitor choice ..:

Tiribelli M ; Latagliata R ; Breccia M...
info:eu-repo/semantics/altIdentifier/pmid/37354090. , 2023

Link: https://hdl.handle.net/1..

5

Safety and efficacy of caplacizumab retreatment in a real-l..:

Caocci, G ; Mulas, O ; Mantovani, D..
info:eu-repo/semantics/altIdentifier/pmid/37348319. , 2023

Link: https://hdl.handle.net/1..

6

Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib..:

Sicuranza A ; Ferrigno I ; Abruzzese E...
info:eu-repo/semantics/altIdentifier/pmid/35178353. , 2022

Link: http://hdl.handle.net/24..

7

Dihydroorotate dehydrogenase inhibition reveals metabolic v..:

Houshmand M ; Vitale N ; Orso F...
info:eu-repo/semantics/altIdentifier/pmid/35773274. , 2022

Link: https://hdl.handle.net/1..

8

Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib..:

Sicuranza A ; Ferrigno I ; Abruzzese E...
info:eu-repo/semantics/altIdentifier/pmid/35178353. , 2022

Link: http://hdl.handle.net/23..

9

Conditioning Regimens in Patients with β-Thalassemia Who Un..:

Mulas O ; Mola B ; Caocci G.
info:eu-repo/semantics/altIdentifier/pmid/35207178. , 2022

Link: http://hdl.handle.net/11..

10

Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib..:

Sicuranza A ; Ferrigno I ; Abruzzese E...
info:eu-repo/semantics/altIdentifier/pmid/35178353. , 2022

Link: https://hdl.handle.net/1..

11

Chronic graft vs. host disease and hypogammaglobulinemia pr..:

Barabino, L ; Galitzia, A ; Murru, R...
info:eu-repo/semantics/altIdentifier/pmid/36524517. , 2022

Link: https://hdl.handle.net/1..

12

Prognostic Factors for Overall Survival In Chronic Myeloid ..:

Specchia G ; Pregno P ; Breccia M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000698018000001. , 2021

Link: http://hdl.handle.net/11..

13

Prognostic Factors for Overall Survival In Chronic Myeloid ..:

Specchia G ; Pregno P ; Breccia M...
info:eu-repo/semantics/altIdentifier/pmid/34513714. , 2021

Link: http://hdl.handle.net/23..

14

Prognostic Factors for Overall Survival In Chronic Myeloid ..:

Specchia G ; Pregno P ; Breccia M...
info:eu-repo/semantics/altIdentifier/pmid/34513714. , 2021

Link: https://hdl.handle.net/1..

15

Thyroid autoimmunity and hypothyroidism are associated with..:

Rodia, R ; Pani, F ; Caocci, G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783879/. , 2021

Link: http://www.ncbi.nlm.nih...